Literature DB >> 6767782

Monohydroxyeicosatetraenoic acids (HETEs) induce degranulation of human neutrophils.

W F Stenson, C W Parker.   

Abstract

5-S-hydroxy-6,8,11,14-eicosatetraenoic acid (5-HETE), a lipoxygenase product in neurophils, and 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE), a lipoxygenase product in platelets, were prepared biosynthetically and incubated with purified human peripheral neutrophils. Both 5-HETE and 12-HETE at 5- to 10-microM concentrations induced degranulation of specific granules. Both 5-HETE and 12-HETE are chemotactic for neutrophils at these concentrations. Arachidonic acid, the metabolic precursor of 5-HETE and 12-HETE, did not induce degranulation. The calcium ionophore A23187 induces neutrophils degranulation and also activates arachidonic acid metabolism in neutrophils resulting in 5-HETE production. Both ionophore-induced 5-HETE production and ionophore-induced degranulation can be inhibited, with very similar inhibition curves, by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonate metabolism. We propose that the mechanism for 5-HETE- and 12-HETE-induced degranulation is an alteration in the fatty acid composition of membrane phospholipids.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6767782

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Recombinant human tumour necrosis factor (rTNF)2 enhances leukotriene biosynthesis in neutrophils and eosinophils stimulated with the Ca2+ ionophore A23187.

Authors:  R Roubin; P P Elsas; W Fiers; A J Dessein
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

2.  Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.

Authors:  T R Martin; G Raugi; T L Merritt; W R Henderson
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

Review 3.  Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor.

Authors:  A G Rossi; J T O'Flaherty
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis.

Authors:  R A Hilger; K Neuber; W König
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

5.  Effects of a calmodulin inhibitor on bleomycin-induced lung inflammation in hamsters. Biochemical, morphometric, and bronchoalveolar lavage data.

Authors:  J M Nakashima; D M Hyde; S N Giri
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

6.  Effect of the PAF-receptor antagonist SM-12502 on human platelets.

Authors:  M Köller; R A Hilger; W König
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

7.  Nitric oxide enhances 12-HETE versus LTB4 generation in pancreatic transplantation.

Authors:  G Hotter; D Closa; F Pí; L Fernández-Cruz; E Gelpí; J Roselló-Catafau
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

8.  Regulation of phosphatidylinositol turnover, calcium metabolism and enzyme secretion by phorbol dibutyrate in neutrophils.

Authors:  C M Kramer; R C Franson; R P Rubin
Journal:  Lipids       Date:  1984-05       Impact factor: 1.880

9.  Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.

Authors:  W F Stenson; E Lobos
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

10.  Differential effects of putative lipoxygenase inhibitors on arachidonic acid metabolism in cell-free and intact cell preparations.

Authors:  J Chang; M D Skowronek; M L Cherney; A J Lewis
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.